ClinicalTrials.gg
CompletedNCT03355118Updated Jun 30, 2022

Oxygen Extraction and Delivery in Elderly During Major Surgery

An observational study in Impaired Oxygen Delivery, Surgery and Postoperative Complications, sponsored by Karolinska Institutet. Completed at 1 site in Sweden. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2022-06-30.

Sponsored by Karolinska Institutet · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
20
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 46 studies in Postoperative Complications with a site in Sweden — 10 open to participants now, 14 under way, 1 of them phase 3. Postoperative Complications · Sweden.

Enrollment
19th of 21
20 · median 216
Started
2017
with 3 others
Observational
21 of 46
3 open now
Registered
20th of 46
by date
Lead sponsor
6 of 46
Karolinska Institutet

Among the 46 studies in Postoperative Complications with a site in Sweden, this one is the 19th largest by enrollment of the 21 observational ones that give a count, is one of 4 that started in 2017, is one of 21 observational ones, and was the 20th registered.

Postoperative Complications

1,332 studies on the registry are indexed under Postoperative Complications; 311 are open to participants now.

Browse Postoperative Complications studies →

Open to participants now

10 of the 46 studies in Postoperative Complications with a site in Sweden are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 202 Postoperative Complications studies recruiting now, 126 (62%) set no upper age limit and 32 (16%) stop at 75 or younger; 25 take children under 18; 25 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 46 studies in Postoperative Complications with a site in Sweden, or all of them as a file.
02

Study summary

This clinical observational study investigates perioperative oxygen consumption and delivery in elderly patients undergoing major surgery. The primary objectives are to characterise the perioperative oxygen delivery, consumption and potential markers of oxygen debt. Secondary objective is to estimate the correlation between oxygen delivery/consumption and postoperative outcomes to guide the design of a future trial.

Read the detailed description

Background Intra- and postoperative fluid therapy aims to achieve or maintain pre-specified thresholds of oxygen delivery/blood flow which can be accomplished by use of fluids with or without inotropic drugs. The used thresholds of oxygen delivery were suggested over 40 years ago, in considerably younger patients compared to the current patients. Update of the characteristics of perioperative oxygen delivery and consumption is reasonable in modern clinical settings.

Primary outcome:

relative changes of oxygen consumption induced by anaesthesia

Secondary outcomes:

relative changes of oxygen consumption and delivery during surgery and postoperatively, oxygen extraction ratio (measured and estimated), potential markers of oxygen debt frequency of in-hospital postoperative complications, mortality (30 Days)

Population:

Men and women ≥65 years undergoing major/complex surgical procedures, when intra-operative cardiovascular monitoring is justified according to clinical decision.

Intervention: no study related intervention, general anaesthesia and surgery according to clinical routine

Blinding: no blinding

Study size:

Pilot study 1: feasibility assessment of study protocol of intra-operative measurements (n= max 10) Pilot study 2: feasibility assessment of study protocol of postoperative measurements (n= max 10) Main study: 60 subjects (20+´40) Planned analysis of oxygen consumption after 20 monitored subjects

Study duration:

Duration of haemodynamic monitoring 24-36 hours Duration of observation of clinical outcomes: 7-10 days, mortality at 30 days postop.

Investigational events:

monitoring of oxygen consumption and delivery monitoring of postoperative clinical outcomes monitoring of markers of tissue injury

Assessments, Procedures and Schedule of Investigational Events:

Subjects are identified by the operation planning list and assessed for eligibility. The study information will be given verbal during the first hospital visit. Subjects who give written informed consent will be included in the study.

Measurements:

oxygen consumption by indirect calorimetry via face mask (in awake state) and via expiratory extension tube of anaesthesia machine (unconscious state) cardiac output monitoring via arterial line (LiDCO) blood samples: arterial and venous blood gase samples, Troponin-T urine samples: N-gal

Clinical outcomes:

Data collection from medical records on postoperative complications using the POMS (postoperative morbidity survey) screening survey at days 3,7 and 10. Postoperative mortality at day 30.

03

Conditions studied

  • Impaired Oxygen Delivery
  • Surgery
  • Postoperative Complications
  • Peroperative Complication
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Men and women ≥65 years undergoing major/complex surgical procedures at the Karolinska University Hospital in Huddinge, Stockholm

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Men and women aged ≥65 years
  2. Major/complex surgery (BUPA AXA classification of surgical severity)
  3. Central and arterial venous catheterization for hemodynamic monitoring.
  4. Written
  5. Available research team for the measurements If two subjects are eligible the elder one will be chosen. If there are two subjects eligible of different gender and almost the same age, the subject with a gender that is underrepresented by two or more will be chosen. This is consistent with the purpose of including subjects with as high age as possible without interfering with recruitment.

Exclusion criteria

Exclusion Criteria

  1. Concomitant medication with Lithium (interferes with calibration of the LiDCO monitor)
  2. Weight≤ 40 kg.
  3. Not possible to establish arterial or central venous line.
  4. Planned postoperative care at high-dependency unit (POP/IMA) \<12hrs.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No

Interventions

  • OtherGeneral anaesthesia and major surgery

    The effect of general anaesthesia and surgery on oxygen transport and how it relates to outcome

06

What researchers measure

Primary outcomes

  1. oxygen consumption

    change of oxygen consumption after anaesthesia induction

    Time frame: prior to and 15 minutes after anaesthesia induction

Secondary outcomes

  1. oxygen consumption

    changes of oxygen consumption during surgery and postoperative recovery

    Time frame: perioperatively 0-36hrs

  2. oxygen extraction ratio

    ratio between oxygen consumption and oxygen delivery

    Time frame: perioperatively 0-36hrs

  3. oxygen extraction ratio: estimated and measured

    ratio between oxygen consumption and oxygen delivery estimated from blood gases and measured by indirect calorimetry and cardiac output monitoring

    Time frame: perioperatively 0-36hrs

  4. C(v-a)pCO2/C(a-v)O2

    Ratio: venoarterial pCO2 difference/arterio-venous oxygen content difference

    Time frame: perioperatively 0-36hrs

  5. postoperative complications

    postoperative complications described by Postoperative Morbidity Survey (8)

    Time frame: postoperative days 3,5 and 10

  6. mortality

    postoperative mortality

    Time frame: postoperative days 30

07

Study locations

1 site
  • Karolinska University hospital Huddinge
    Stockholm, 141 86, Sweden
08

References and documents

Publications

  • Jakobsson J, Noren C, Hagel E, Kalman S, Bartha E. Peri-operative oxygen consumption revisited: An observational study in elderly patients undergoing major abdominal surgery. Eur J Anaesthesiol. 2021 Jan;38(1):4-12. doi: 10.1097/EJA.0000000000001302. PubMed 32858583 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2017 to primary completion in Mar 2018, 3 months.

Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's 3 months is below that.

Counting every sponsor, half of 281 studies reached it within 23 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 22, 2017
First posted
Nov 28, 2017
StartActual
Nov 27, 2017
Primary completionActual
Mar 23, 2018
CompletionActual
Apr 4, 2018
Last update
Jun 30, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 30, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03355118
Responsible party
Sigridur Kalman (Professor, Senior Consultant, Karolinska Institutet) — Principal investigator
First posted
Nov 28, 2017
Start date
Nov 27, 2017
Primary completion
Mar 23, 2018
Completion
Apr 4, 2018
Last update
Jun 30, 2022

Study contacts

Erzsebet Bartha, MD PhD
study director · Karolinska University Hospital Huddinge, Stockholm, Sweden
Julia Jakobsson, MD
principal investigator · Karolinska University Hospital Huddinge, Stockholm, Sweden

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion